BackD. Western Therapeutics Institute Overview

D. Western Therapeutics Institute Current Cash

Track D. Western Therapeutics Institute's current cash ($1.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.58B
↑ 50.93% YoYΔ $533.68M vs prior year quarter

Peer trimmed avg / median

Loading

D. Western Therapeutics Institute Current Cash History

Loading

D. Western Therapeutics Institute vs. peers: Current Cash Comparison

Loading

D. Western Therapeutics Institute Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

D. Western Therapeutics Institute (4576.T) FAQ

As of the most recent data (June 2026), 4576.T shows a current cash of $1.6B. That compares with $1B in the prior-year period — up 50.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4576.T's current cash is now $1.6B (was $1B) — a 50.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether D. Western Therapeutics Institute is outperforming or lagging.

Tracking 4576.T's current cash over time shows whether D. Western Therapeutics Institute is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6B That compares with $1B in the prior-year period — up 50.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has D. Western Therapeutics Institute's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.6B) with ownership activity and broader fundamentals.

D. Western Therapeutics Institute's current cash is $1.6B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.